Janus Henderson Group’s Idexx Laboratories IDXX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$6.06M Sell
10,790
-1,749
-14% -$1.12M ﹤0.01% 903
2025
Q4
$8.48M Sell
12,539
-33
-0.3% -$22.5K ﹤0.01% 782
2025
Q3
$8.03M Buy
12,572
+1,738
+16% +$1.05M ﹤0.01% 793
2025
Q2
$5.81M Sell
10,834
-1,721
-14% -$823K ﹤0.01% 859
2025
Q1
$5.22M Buy
12,555
+908
+8% +$394K ﹤0.01% 870
2024
Q4
$4.82M Sell
11,647
-187
-2% -$82K ﹤0.01% 927
2024
Q3
$5.98M Buy
11,834
+53
+0.4% +$25.7K ﹤0.01% 830
2024
Q2
$5.74M Sell
11,781
-626
-5% -$314K ﹤0.01% 799
2024
Q1
$6.7M Sell
12,407
-499
-4% -$273K ﹤0.01% 782
2023
Q4
$7.17M Buy
12,906
+135
+1% +$63.4K ﹤0.01% 725
2023
Q3
$5.59M Buy
12,771
+746
+6% +$372K ﹤0.01% 791
2023
Q2
$6.04M Sell
12,025
-990
-8% -$474K ﹤0.01% 808
2023
Q1
$6.51M Buy
13,015
+2,547
+24% +$1.22M ﹤0.01% 802
2022
Q4
$4.27M Sell
10,468
-10,470
-50% -$4.06M ﹤0.01% 897
2022
Q3
$6.83M Sell
20,938
-218,068
-91% -$80.1M ﹤0.01% 911
2022
Q2
$83.8M Sell
239,006
-7,123
-3% -$2.9M 0.06% 286
2022
Q1
$135M Buy
246,129
+223,208
+974% +$117M 0.07% 267
2021
Q4
$15.1M Sell
22,921
-11,739
-34% -$7.37M 0.01% 840
2021
Q3
$21.6M Sell
34,660
-6,127
-15% -$4.12M 0.01% 776
2021
Q2
$25.8M Sell
40,787
-554
-1% -$306K 0.01% 737
2021
Q1
$20.2M Buy
41,341
+4,540
+12% +$2.27M 0.01% 767
2020
Q4
$18.4M Sell
36,801
-5,726
-13% -$2.56M 0.01% 770
2020
Q3
$16.7M Sell
42,527
-47,905
-53% -$17.7M 0.01% 745
2020
Q2
$29.9M Sell
90,432
-95,240
-51% -$27.6M 0.02% 610
2020
Q1
$45M Sell
185,672
-361,528
-66% -$94.3M 0.03% 479
2019
Q4
$143M Sell
547,200
-18,422
-3% -$4.85M 0.07% 278
2019
Q3
$154M Buy
565,622
+23,637
+4% +$6.58M 0.08% 263
2019
Q2
$149M Sell
541,985
-164,106
-23% -$40.4M 0.08% 275
2019
Q1
$158M Sell
706,091
-331,539
-32% -$68.4M 0.09% 272
2018
Q4
$193M Buy
1,037,630
+642,220
+162% +$132M 0.12% 210
2018
Q3
$98.7M Buy
395,410
+69,128
+21% +$16.8M 0.05% 401
2018
Q2
$71.1M Sell
326,282
-110,493
-25% -$22.8M 0.04% 462
2018
Q1
$83.6M Sell
436,775
-453,161
-51% -$83.6M 0.05% 418
2017
Q4
$139M Sell
889,936
-172,549
-16% -$27.2M 0.08% 275
2017
Q3
$165M Sell
1,062,485
-69,417
-6% -$11M 0.11% 241
2017
Q2
$183M Buy
1,131,902
+938,888
+486% +$152M 0.12% 219
2017
Q1
$29.8M Sell
193,014
-18,723
-9% -$2.58M 0.21% 113
2016
Q4
$24.8M Sell
211,737
-25,993
-11% -$2.97M 0.18% 148
2016
Q3
$26.8M Sell
237,730
-8,506
-3% -$896K 0.2% 137
2016
Q2
$22.8M Sell
246,236
-24,374
-9% -$2.09M 0.19% 148
2016
Q1
$21.2M Sell
270,610
-29,612
-10% -$2.13M 0.17% 155
2015
Q4
$21.9M Sell
300,222
-9,731
-3% -$694K 0.18% 153
2015
Q3
$23M Sell
309,953
-16,146
-5% -$1.16M 0.2% 140
2015
Q2
$20.9M Sell
326,099
-123,213
-27% -$8.53M 0.16% 160
2015
Q1
$29.3M Sell
449,312
-37,236
-8% -$2.9M 0.23% 121
2014
Q4
$36.1M Buy
+486,548
New +$34.1M 0.26% 103

Other funds holding IDXX

Janus Henderson Group's IDXX Position: Q1 2026 in Review

Janus Henderson Group reduced its Idexx Laboratories (IDXX) stake by 14% in Q1 2026, selling an estimated $1.12M and leaving 10,790 shares worth $6.06M. The position accounts for ﹤0.01% of the portfolio, ranked #903.

Janus Henderson Group first reported a position in IDXX in Q4 2014 and has held it in 46 quarters since. The position peaked at $193M in Q4 2018. 1,311 funds tracked by Wall St. Rank hold IDXX as of Q1 2026.

  • Janus Henderson Group held 10,790 shares of Idexx Laboratories worth $6.06M as of Q1 2026.
  • Janus Henderson Group sold 1,749 Idexx Laboratories shares in Q1 2026, an estimated $1.12M.
  • Idexx Laboratories made up ﹤0.01% of Janus Henderson Group's portfolio in Q1 2026, its #903 holding.
  • Janus Henderson Group first reported a position in Idexx Laboratories in Q4 2014 and has held it in 46 quarters since.
  • Janus Henderson Group's Idexx Laboratories position peaked at $193M in Q4 2018.
  • 1,311 funds tracked by Wall St. Rank held Idexx Laboratories as of Q1 2026.

Based on Janus Henderson Group's 13F filing for Q1 2026, filed 15 May 2026.